Cholangitis

As many as 1 in 4 U.S. military veterans with the liver disease primary biliary cholangitis (PBC) may have irreversible liver scarring, or cirrhosis,…

Various factors, including male sex and younger age, were associated with an increased risk of primary sclerosing cholangitis (PSC) recurrence after liver transplant, according…

A team of scientists has identified two key immune proteins — CD58 and IL7R — as therapeutic targets in primary biliary cholangitis (PBC), with…

Gilead Sciences‘ Livdelzi (seladelpar) effectively reduces blood levels of alkaline phosphatase (ALP), a key marker of liver damage, in most people with primary…

Assembly Biosciences plans to develop its investigational oral treatment, ABI-6250, for people with primary biliary cholangitis (PBC) or primary sclerosing cholangitis (PSC). The…

People with primary biliary cholangitis (PBC) who experience itching (pruritus) use more healthcare resources and have significantly higher medical costs than those without this…

Low blood levels of vitamin B6 — found in certain foods and essential for metabolism and immune function in the body — can increase the…

Twice-daily treatment with volixibat, Mirum Pharmaceuticals’ oral investigational therapy for primary sclerosing cholangitis (PSC) significantly outperformed a placebo in reducing moderate to severe…

Adults with primary biliary cholangitis (PBC) who have less elevated blood levels of the liver enzyme alkaline phosphatase (ALP), a marker of liver damage, at…

Scheduled MRI scans one to three years after a liver transplant may detect signs of returning primary sclerosing cholangitis (PSC) earlier than standard blood-based liver…